Clermont-Ferrand, 2 March 2020 – (FR0004177046 METEX), METabolic EXplorer (METEX), a cleantech biochemical company that develops and industrialises competitive and sustainable fermentation processes offering alternatives to petrochemistry for the production and marketing of functional ingredients, announces the signing of an agreement between its subsidiary METEX NØØVISTA and ALINOVA for the marketing in France of the first bio-based butyric acid on the animal nutrition market.
This partnership, which is part of the Group’s commercial strategy, structures the marketing on the animal nutrition market of the second ingredient that will be produced at the plant of its subsidiary METEX NØØVISTA.
As a reminder, METEX’s ambition is to become an industrial leader in the production and marketing of functional ingredients produced by fermentation and to meet consumer demand for naturalness in the cosmetics as well as the animal and human nutrition markets.
Following the agreement with DSM for the marketing of PDO on the cosmetics market, METEX is taking another step in its development with the marketing of a second product, bio-based butyric acid, through its subsidiary METEX NØØVISTA. Butyric acid and its derivatives are multifunctional ingredients with proven and recognised benefits for animal growth and health. They act on the intestinal functions of animals by improving nutrient absorption and strengthening the defenses of epithelial cells.
This agreement confirms the demand for bio-based functional ingredients in the animal nutrition market.
After the sale to Evonik in 2016 of the inoLa technology, the first process for producing 100% bio-based L-Methionine, butyric acid is METEX’s second contribution to animal nutrition. Consumer expectations in terms of health and well-being are translating into strong demand for natural, eco-designed ingredients. METEX butyric acid and its derivatives will be the first natural alternative to the product currently available in the animal nutrition market, which is made from petrochemicals
Benjamin Gonzalez, Chairman and CEO of METEX, says: “With this first commercial partnership for the marketing of butyric acid, METEX demonstrates the merits of the product and the market interest in natural solutions for animal feed and thus contributes to achieving the United Nations’ health and well-being sustainability goal.”
Jean-Michel Boussit, CEO of AXEREAL Elevage, says: “Through ALINOVA and this partnership with METEX NØØVISTA, AXEREAL strengthens its position in the market for performance-enhancing nutritional ingredients of natural origin that contribute to the development of responsible industries, which are crucial to meeting the future challenges for animal production in Europe”.
The METEX NØØVISTA and ALINOVA press release concerning this agreement can be viewed on www.metabolic-explorer.com (Press Releases).
About METabolic EXplorer – www.metabolic-explorer.com
Using renewable raw materials, the company develops and industrialises innovative and competitive industrial fermentation processes as alternative to petrochemical processes to meet consumers’ new societal expectations and the objectives of the energy transition. Its functional ingredients of natural origin are used in the formulation of cosmetic products, nutrition-animal health or as intermediates for the synthesis of biomaterials.
The construction of its first production unit, through its subsidiary METEX NØØVISTA, will bring 1.3 propanediol (PDO) and butyric acid (BA) on the market.
Based at the Clermont Limagne technology park, near Clermont-Ferrand, METabolic EXplorer is listed on Euronext in Paris (Compartment C, METEX) and is included in the CAC Small Index.
Get free financial information on METabolic EXplorer by registering with:
Alinova develops and markets nutritional supplements and additive premixes via its distribution network (feed manufacturers, integrators, groups, veterinary networks, etc.). Since its creation, Alinova has offered, along with other products, natural solutions to recurring problems in livestock production. To provide these solutions, Alinova develops fully certified and therefore transparent phytotherapeutic products as well as liquid vitamins without the use of chemical surfactants.
The company recently acquired a 3,600-m2 production building. In the future, this facility will have a liquid and powder unit as well as a laboratory to carry out galenical testing. With this industrialisation phase, Alinova will gain more autonomy and the capacity to export its products.
Alinova SAS is based at Saint Brandan, near Saint Brieuc, in northwestern France.
Investor relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : email@example.com
Media relations – ACTIFIN –
Tél : + 33 (0) 1 56 88 11 11
mail : firstname.lastname@example.org